AI assistant
PFIZER INC — Director's Dealing 2010
Mar 2, 2010
29831_dirs_2010-03-01_56aad4a2-0f25-41d4-af09-65207da97d1e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2010-02-25
Reporting Person: CANGIALOSI LORETTA V (Sr. Vice President, Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-02-25 | Common Stock | A | 8148 | — | Acquired | 187008 | Direct |
| 2010-02-25 | Common Stock | A | 2951 | — | Acquired | 189959 | Direct |
| 2010-02-25 | Common Stock | F | 1069 | $17.69 | Disposed | 188890 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-02-25 | Stock Appreciation Rights | $17.69 | A | 32939 | Acquired | 2015-02-25 | Common Stock (32939) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2641 | Indirect |
Footnotes
F1: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
F2: The reported transaction constitutes the earn-out of Performance-Contingent Shares.
F3: The reported transaction constitutes withholding of shares to satisfy tax obligations upon the earn-out of Performance-Contingent Shares.
F4: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.